BIT Capital GmbH Has $14.84 Million Holdings in Omada Health, Inc. $OMDA

BIT Capital GmbH raised its position in Omada Health, Inc. (NASDAQ:OMDA) by 52.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 940,238 shares of the company’s stock after buying an additional 323,365 shares during the period. BIT Capital GmbH owned 1.62% of Omada Health worth $14,837,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Strs Ohio acquired a new position in Omada Health in the third quarter valued at about $38,000. Raymond James Financial Inc. bought a new position in shares of Omada Health in the second quarter worth about $32,000. TD Waterhouse Canada Inc. bought a new position in shares of Omada Health in the fourth quarter worth about $32,000. Inlight Wealth Management LLC bought a new position in shares of Omada Health in the fourth quarter worth about $45,000. Finally, JPMorgan Chase & Co. bought a new position in shares of Omada Health in the third quarter worth about $82,000.

Insider Buying and Selling

In related news, CEO Sean P. Duffy sold 4,063 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $14.34, for a total transaction of $58,263.42. Following the completion of the sale, the chief executive officer directly owned 117,598 shares of the company’s stock, valued at $1,686,355.32. The trade was a 3.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Steven L. Cook sold 1,884 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $13.94, for a total transaction of $26,262.96. Following the sale, the chief financial officer directly owned 200,512 shares of the company’s stock, valued at approximately $2,795,137.28. This trade represents a 0.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 8,776 shares of company stock valued at $120,483 over the last ninety days. Insiders own 6.38% of the company’s stock.

Omada Health Price Performance

OMDA opened at $17.93 on Friday. The company has a market cap of $1.07 billion and a price-to-earnings ratio of -66.41. The firm has a 50 day simple moving average of $14.83 and a 200 day simple moving average of $14.88. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $28.40.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The business had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. As a group, analysts expect that Omada Health, Inc. will post -0.01 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on OMDA shares. Canaccord Genuity Group set a $24.00 target price on shares of Omada Health in a research note on Friday, May 8th. Citizens Jmp boosted their target price on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research note on Friday, May 8th. Evercore reaffirmed an “outperform” rating and issued a $20.00 target price on shares of Omada Health in a research note on Friday, May 8th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Finally, BMO Capital Markets dropped their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Ten analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $22.91.

Omada Health Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.